As of 2025-12-22, the Intrinsic Value of Sana Biotechnology Inc (SANA) is -4.40 USD. This SANA valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.36 USD, the upside of Sana Biotechnology Inc is -200.92%.
Based on its market price of 4.36 USD and our intrinsic valuation, Sana Biotechnology Inc (SANA) is overvalued by 200.92%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.40 - -4.40 | -4.40 | -200.92% |
| P/E | (12.67) - (15.49) | (13.90) | -418.9% |
| DDM - Stable | (5.86) - (17.97) | (11.91) | -373.2% |
| DDM - Multi | (5.69) - (13.93) | (8.12) | -286.2% |
| Market Cap (mil) | 1,161.37 |
| Beta | 1.19 |
| Outstanding shares (mil) | 266.37 |
| Enterprise Value (mil) | 1,058.02 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.46% |
| Cost of Debt | 5.00% |
| WACC | 7.57% |